Open Innovation

R&D Funding:


Could your innovative drug research turn an existing Bayer compound into a novel therapy for a new patient group? We are crowdsourcing the exploration of our compounds in therapeutic indications outside of our own R&D focus.

submission closed
September 30 2017

Who this is for

  • universities
  • other academic research institutes
  • startup and biotech companies

all over the world with an interest in pharmaceutical R&D

What it’s about

New indications for Bayer compounds:

  • preclinical studies
  • clinical studies
  • exploring an indication outside our own research areas
  • maximum duration of two years

More Details +

We offer

  • a research grant for your full study proposal (upon invitation after a successful short proposal)
  • further funding to support your preclinical or clinical study (separate IIR contract))
  • supply of the Bayer compound you need for your research

More Details +

Submission deadlines

September 30, 2017

Stay tuned for more news

Thanks for signing up.
You'll hear from us soon.

Close Window